Jiandong Mei

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Shun Lü, Wei Zhang, Lin Wu et al. · JAMA · 2024 · 336 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Interleukin-17 and Prostaglandin E2 Are Involved in Formation of an M2 Macrophage-Dominant Microenvironment in Lung Cancer

Lunxu Liu, Dongxia Ge, Lin Ma et al. · Journal of Thoracic Oncology · 2012 · 132 citations · Full text

Life Sciences, Immunology, Oncology +16

Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines

Lingyun Yang, Feng Huang, Jiandong Mei et al. · International Journal of Gynecological Cancer · 2016 · 97 citations

Medicine, Cell Biology, Oncology +15

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 88 citations

Medicine, Perioperative Medicine, Pharmacology +13

Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer

Zhongfu Mo, Jing Liu, Qiuyang Zhang et al. · Oncology Letters · 2016 · 87 citations · Full text

Medicine, Oncology, Pathology +17